Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s13256-017-1272-9.pdf
Reference16 articles.
1. Daugaard G. Management of poor-prognosis or relapsed germ-cell cancer. BJU Int. 2009;104(9 Pt B):1392–7. doi: 10.1111/j.1464-410X.2009.08865.x .
2. Einhorn LH. Curing metastatic testicular cancer. Proc Natl Acad Sci U S A. 2002;99(7):4592–5. doi: 10.1073/pnas.072067999 .
3. Feldman DR, Huddart R, Hall E, Beyer J, Powles T. Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial. J Cancer. 2011;2:374–7.
4. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357(4):340–8. doi: 10.1056/NEJMoa067749 .
5. Hoshi S, Itoh A, Kato S, Suzuki K, Kawamura S, Orikasa S. Severe rhabdomyolysis as a complication of high-dose chemotherapy in a patient with advanced testicular cancer. Int J Urol. 1999;6(1):56–8.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19-associated rhabdomyolysis: A scoping review;International Journal of Infectious Diseases;2023-11
2. Case Report: Etoposide-nedaplatin induced rhabdomyolysis in a small cell lung cancer patient;Frontiers in Pharmacology;2023-08-22
3. Electrolytes disturbances in cancer patients;Current Opinion in Nephrology & Hypertension;2022-07-18
4. Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report;Cancer Reports;2022-07-13
5. Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review;European Journal of Medical Research;2022-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3